Alterations in GABA(A) receptor α1 and α4 subunit mRNA levels in thalamic relay nuclei following absence-like seizures in rats

Experimental Neurology

Volumn 154, Issue 1, 1998, Pages 213-223

  Banerjee, Pradeep K ^a,b   Tillakaratne, Niranjala J K ^c   Brailowsky, Simon ^e   Olsen, Richard W ^c   Tobin, Allan J ^c,d   Snead III, O Carter ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Absence seizures; GABA(A) receptor subunits; Gene expression; mRNA; Thalamus; hydroxybutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; MESSENGER RNA; RECEPTOR SUBUNIT; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; GAMMA BUTYROLACTONE; ORGANOPHOSPHORUS COMPOUND;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IN SITU HYBRIDIZATION; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RNA ANALYSIS; SPIKE WAVE; THALAMUS NUCLEUS; ANIMAL; CHEMICALLY INDUCED DISORDER; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; METABOLISM; SPRAGUE DAWLEY RAT; THALAMUS; TIME;

4-BUTYROLACTONE; ANIMALS; EPILEPSY, ABSENCE; GABA ANTAGONISTS; GABA MODULATORS; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; THALAMUS; TIME FACTORS;

EID: 0032196494     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6928     Document Type: Article

References (40)

1. 3. Neuroscience. 56:1993;11-22.
2. Banerjee P. K., Snead O. C. Thalamic mediodorsal and intralaminar nuclear lesions disrupt the generation of experimentally induced generalized absence-like seizures in rats. Epilepsy Res. 17:1994;193-205.
3. A. J. Neurochem. 69:1997;806-814.
4. A. Mol. Brain Res. 26:1994;309-319.
5. Cox K. H., DeLeon D. V., Angerer L. M., Angerer R. C. Detection of mRNAs in sea urchin embryos byin situ. Dev. Biol. 101:1984;485-502.
6. Doherty J. D., Hattox S. E., Snead O. C., Roth R. H. Identification of endogenous γ-hydroxybutyrate in human, guinea pig and rhesus monkey brain. J. Pharmacol. Exp. Ther. 20:1978;130-139.
7. 35t. J. Neurosci. 10:1990;603-612.
8. A. J. Comp. Neurol. 359:1995;154-194.
9. Gloor P., Avoli M., Kostopoulos G. Thalamocortical relationships in generalized epilepsy with bilaterally synchronous spike-wave discharge. Generalized Epilepsy: Neurobiological Approaches. 1990;Birkhauser, Boston. p. 190-212.
10. Hendrickson A. E., Tillakaratne N. J. K., Mehra R. D., Esclapez M., Erickson A., Vician L., Tobin A. J. Differential localization of two glutamic acid decarboxylases (GAD65 and GAD67) in adult monkey visual cortex. J. Comp. Neurol. 343:1994;566-581.
11. Hosford D. A., Wang Y., Cao Z. Differential effects mediated by GABAA receptors in thalamic nuclei in 1h/1h model of absence seizures. Epilepsy Res. 27:1997;55-65.
12. Houser C. R., Esclapez M. Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent seizures. Epilepsy Res. 26:1996;207-218.
13. B. J. Neurophysiol. 71:1994;2576-2581.
14. Ain situ. Mol. Brain Res. 31:1995;33-47.
15. Kapur J., Coulter D. A. Experimental status epilepticus alters γ-aminobutyric acid type A receptor function in CA1 pyramidal neurons. Ann. Neurol. 38:1995;893-900.
16. Kaufman D. L., McGinnis J. F., Krieger N. R., Tobin A. J. Brain glutamate decarboxylase cloned in λgt-11: Fusion protein produces γ-aminobutyric acid. Science. 32:1986;1138-1140.
17. A. Neuron. 3:1989;745-753.
18. Kluver N., Barrera E. A method for the combined staining of cells and fibres in the nervous system. J. Neuropath. Exp. Neurol. 12:1953;400-403.
19. Liu Z., Vergnes M., Depaulis A., Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res. 545:1991;1-7.
20. A. Annu. Rev. Neurosci. 17:1994;569-602.
21. A. J. Neurochem. 68:1997;2485-2492.
22. A. Mol. Pharmacol. 42:1992;415-422.
23. 35321414. Neurosci. Lett. 121:1991;211-214.
24. Mirsky A. F., Duncan C. C., Myslobodsky M. S. Petit mal epilepsy: A review and integration of recent information. J. Clin. Neurophysiol. 3:1986;179-208.
25. B. Naunyn Schmiedeb. Arch. Pharmacol. 342:1990;194-197.
26. 3. J. Neurosci. 3:1983;1189-1198.
27. Pritchett D. B., Sonthiemer H., Shivers B. D., Ymer S., Kettenmann H., Schofield P. R., Seeburg P. H. Importance of a novel GABAA subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
28. A. Synapse. 21:1995;189-274.
29. Rice A., Rafiq A., Shapiro S. M., Jakoi E. R., Coulter D. A., DeLorenzo R. J. Long-lasting reduction of inhibitory function and γ-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc. Natl. Acad. Sci. USA. 93:1996;9665-9669.
30. Roth R. H., Giarman N. J. γ-Butyrolactone and γ-hydroxybutyric acid I. The pharmacologically active form. Int. J. Neuropharmac. 5:1969;421-442.
31. A. J. Neurosci. 14:1994;7077-7086.
32. Shumate J. S., Snead O. C. Plasma and central nervous system kinetics of gamma-hydroxybutyrate. Res. Commun. Chem. Pathol. Pharmacol. 25:1977;241-256.
33. A. Nature. 392:1998;926-930.
34. Snead O. C. γ-Hydroxybutyrate model of generalized absence seizures: Further characterization and comparison with other absence models. Epilepsia. 29:1988;361-368.
35. B. Eur. J. Pharmacol. 213:1992;343-349.
36. Vergnes M., Marescaux C., Depaulis A., Micheletti G., Warter J. M. Spontaneous spike and wave discharges in thalamus and cortex in a rat model of genetic petit mal-like seizures. Exp. Neurol. 96:1987;127-136.
37. A. J. Neurosci. 12:1992;1040-1062.
38. Young W. S., Kuhar M. J. Radiohistochemical localization of benzodiazepine receptors in rat brain. J. Pharmacol. Exp. Ther. 212:1980;337-346.
39. -. J. Neurophysiol. 78:1997;2280-2286.
40. A. J. Neurosci. 16:1996;6648-6656.